UM1TR005769
Cooperative Agreement
Overview
Grant Description
New York University Clinical and Translational Science Hub - The New York University (NYU) Clinical and Translational Science Institute (CTSI) is a vibrant public–private collaboration between NYU Langone Health (NYULH), the NYU Grossman School of Medicine and NYU Grossman Long Island School of Medicine; the Family Health Centers at NYULH, our community and patient advisory boards, and all other NYU schools and colleges.
Moreover, our partnerships with NYC Health and Hospitals, the nation’s largest municipal healthcare system; the Nathan Kline Institute, a psychiatric research institute; Kingsborough Community College, and >150 additional community partners allow us to reach all populations across New York City.
Our focus over the next 7 years is to emphasize collaboration as a fundamental approach to advancing clinical translational science (CTS) while overcoming barriers, bridging communities, fostering a well-rounded science workforce, and continuously evaluating and improving the quality and impact of our research.
We will partner with communities to bring research to where people live and promote practice and policy through five overarching aims.
Aim 1: Enhance community-engaged research.
We will leverage our unique strengths collaborating with patient, community, and multisector partners to establish innovative research programs and practice-based learning health systems.
Aim 2: Democratize health informatics (HI) resources.
We will foster a collaborative environment to develop, implement, and disseminate innovative HI resources that enhance the quality, safety, efficiency, and reproducibility of clinical translational research (CTR) and CTS.
Aim 3: Develop a well-rounded workforce to advance CTS.
We will create collaborative learning initiatives that involve research faculty, staff, clinicians, students, and community members.
Aim 4: Catalyze regional and national collaborations to accelerate CTS research.
We will promote and facilitate partnerships at regional and national levels to accelerate CTS research through interdisciplinary team science and knowledge sharing.
Aim 5: Advance clinical trials through collaborative partnerships.
We will develop and implement operational innovations to accelerate start-up and completion of clinical trials, while elevating their quality, safety, effectiveness, and impact.
These goals capitalize on our major strengths, emphasizing collaborations with community and multisector partners, interdisciplinary engagement across NYU and its 11 colleges and schools, and active participation in the CTSA consortium.
For the next 7 years, we envision a future in which scientific breakthroughs more swiftly transition from bench to the bedside and into our communities so every individual receives access to innovative healthcare solutions.
Moreover, our partnerships with NYC Health and Hospitals, the nation’s largest municipal healthcare system; the Nathan Kline Institute, a psychiatric research institute; Kingsborough Community College, and >150 additional community partners allow us to reach all populations across New York City.
Our focus over the next 7 years is to emphasize collaboration as a fundamental approach to advancing clinical translational science (CTS) while overcoming barriers, bridging communities, fostering a well-rounded science workforce, and continuously evaluating and improving the quality and impact of our research.
We will partner with communities to bring research to where people live and promote practice and policy through five overarching aims.
Aim 1: Enhance community-engaged research.
We will leverage our unique strengths collaborating with patient, community, and multisector partners to establish innovative research programs and practice-based learning health systems.
Aim 2: Democratize health informatics (HI) resources.
We will foster a collaborative environment to develop, implement, and disseminate innovative HI resources that enhance the quality, safety, efficiency, and reproducibility of clinical translational research (CTR) and CTS.
Aim 3: Develop a well-rounded workforce to advance CTS.
We will create collaborative learning initiatives that involve research faculty, staff, clinicians, students, and community members.
Aim 4: Catalyze regional and national collaborations to accelerate CTS research.
We will promote and facilitate partnerships at regional and national levels to accelerate CTS research through interdisciplinary team science and knowledge sharing.
Aim 5: Advance clinical trials through collaborative partnerships.
We will develop and implement operational innovations to accelerate start-up and completion of clinical trials, while elevating their quality, safety, effectiveness, and impact.
These goals capitalize on our major strengths, emphasizing collaborations with community and multisector partners, interdisciplinary engagement across NYU and its 11 colleges and schools, and active participation in the CTSA consortium.
For the next 7 years, we envision a future in which scientific breakthroughs more swiftly transition from bench to the bedside and into our communities so every individual receives access to innovative healthcare solutions.
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
New York
United States
Geographic Scope
State-Wide
New York University was awarded
NYU Clinical Translational Science Hub: Advancing Collaborative Research in NYC
Cooperative Agreement UM1TR005769
worth $9,581,287
from National Center for Advancing Translational Sciences in March 2026 with work to be completed primarily in New York United States.
The grant
has a duration of 6 years 9 months and
was awarded through assistance program 93.350 National Center for Advancing Translational Sciences.
The Cooperative Agreement was awarded through grant opportunity Clinical and Translational Science Award (UM1 Clinical Trial Optional).
Status
(Ongoing)
Last Modified 4/6/26
Period of Performance
3/20/26
Start Date
12/31/32
End Date
Funding Split
$9.6M
Federal Obligation
$0.0
Non-Federal Obligation
$9.6M
Total Obligated
Activity Timeline
Additional Detail
Award ID FAIN
UM1TR005769
SAI Number
UM1TR005769-3241706777
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75NR00 NIH National Center for Advancing Translational Sciences
Funding Office
75NR00 NIH National Center for Advancing Translational Sciences
Awardee UEI
M5SZJ6VHUHN8
Awardee CAGE
3D476
Performance District
NY-90
Senators
Kirsten Gillibrand
Charles Schumer
Charles Schumer
Modified: 4/6/26